Nalmefene to Treat Alcohol Addiction

Nalmefene is a drug especially helpful for individuals struggling with moderate to severe alcohol use. Nalmefene is used to reduce alcohol cravings and lower intake without requiring daily dosing. It works by blocking opioid receptors in the brain, weakening alcohol’s rewarding effects. 

In 2024, the FDA approved Zurnai, the first nalmefene auto-injector for opioid overdose reversal. In Florida, where over 17% of adults report binge drinking, flexible treatment tools like nalmefene support harm reduction when complete abstinence isn’t immediately possible. 

Typically taken as-needed in 18 mg doses before drinking, nalmefene is linked to reduced heavy drinking days and overall alcohol intake. 

Side effects of Nalmefene include nausea, dizziness, and insomnia, and some rare psychiatric effects are also reported. Alternatives for Nalmefene, like Naltrexone, Acamprosate, and Disulfiram, are FDA-approved options, each with different mechanisms and treatment goals.

What Is Nalmefene?

Nalmefene is a prescription opioid antagonist and receptor modulator used in the treatment of alcohol use disorder (AUD). Marketed under the brand name Selincro in some regions, Nalmefene works by selectively interacting with the brain’s opioid receptors, blocking the mu- (μ) and delta- (δ) opioid receptors while partially activating the kappa-opioid receptor. This action helps reduce the rewarding effects of alcohol and eases withdrawal-related discomfort. Nalmefene is taken as needed, making it a flexible option for managing alcohol dependence.

What is the Chemical Composition of Nalmefene?

Nalmefene has the chemical formula C21H25NO3 and a molecular weight of 339.43 g/mol. It is structurally related to naltrexone and acts as a synthetic opioid receptor modulator. Nalmefene’s structure allows it to bind selectively to mu- (μ), delta- (δ), and kappa-opioid receptors, with a distinct activity that supports its use in reducing alcohol cravings and consumption.

Is Nalmefene FDA Approved for Alcohol Dependence?

No, Nalmefene is not FDA-approved for alcohol dependence in the United States. Although it is recognized as a prescription medication by the European Medicines Agency (EMA) for alcohol addiction treatment in Europe under the brand name Selincro, the FDA has not authorized its use in the U.S. due to limited regulatory submissions. 

What is the Mechanism of Action of Nalmefene?

The mechanism of action of Nalmefene is modulating the brain’s opioid system to reduce the rewarding effects of alcohol. It acts as an antagonist at mu- (μ) and delta- (δ) opioid receptors, blocking the activation triggered by alcohol consumption. This inhibition prevents the release of endorphins, which in turn reduces dopamine levels in the nucleus accumbens, a key part of the brain’s reward system. As a result, the pleasurable sensations associated with drinking are diminished, leading to a reduced urge to consume alcohol.

Nalmefene has partial agonist activity at the kappa (κ) opioid receptor, which helps counteract the dysphoria and stress-related cravings seen with total opioid antagonism. This balanced receptor activity makes Nalmefene particularly effective for individuals who drink to alleviate stress or emotional discomfort.

How Is Nalmefene Used in Alcohol Addiction Treatment?

Nalmefene is used in alcohol addiction treatment as a targeted, as-needed medication to help reduce alcohol consumption in individuals with alcohol use disorder (AUD). Patients are advised to take Nalmefene 1 to 2 hours before they expect to drink. This approach allows for moderation without requiring complete abstinence, supporting autonomy and gradual behavior change.

A 2019 phase-IV clinical trial by Barrio P, Roncero C, Ortega L, Guardia J, Yuguero L, Gual A. et al. titled “The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV Trial,” demonstrated that long-term use of Nalmefene alongside psychosocial support helps in alcohol addiction treatment and reduces alcohol consumption by 40% to 60% over 6 months.

What Are the Other Uses of Nalmefene?

The other uses of Nalmefene include its application in treating opioid overdose. Nalmefene’s longer half-life provides extended protection against respiratory depression from long-acting opioids. Early research also indicates Nalmefene helps manage behavioral addictions like pathological gambling by modulating the brain’s reward pathways and reducing compulsive behavior.

Does Insurance Cover Nalmefene Treatment in Florida?   

Yes, insurance covers Nalmefene treatment in Florida. Florida Medicaid includes Nalmefene (Opvee, Zurnai) on its Preferred Drug List, indicating coverage for eligible beneficiaries. Private insurers, such as Cigna and UnitedHealthcare, offer coverage for Nalmefene, but policies differ. It’s necessary to verify your insurance coverage by reaching out to local health navigators or treatment centers that offer insurance verification services.

What Is the Recommended Dosage of Nalmefene?

The recommended dosage of Nalmefene for alcohol dependence is one 18 mg tablet taken on an as-needed basis, 1 to 2 hours before a planned drinking occasion. Dosage adjustments are required in cases of adverse effects like nausea, dizziness, or insomnia. 

Patients with impaired liver or kidney function need alternative treatment plans due to altered drug metabolism, and Nalmefene is not recommended for those with severe hepatic or renal impairment or those experiencing acute alcohol withdrawal. 

How Is Nalmefene Taken?  

Nalmefene is taken primarily in oral tablet form, with an 18 mg dose used on an as-needed basis before anticipated alcohol consumption. In rare or investigational cases, it is administered intravenously for opioid overdose treatment.

Nalmefene is taken in the following ways:

• Oral Administration (Tablets): Nalmefene is most commonly taken orally by individuals who aim to reduce drinking rather than achieve total abstinence.
  
• Intravenous (IV) Administration (Investigational Use): Nalmefene has also been explored in IV form for opioid overdose treatment, but IV use is reserved for investigational or emergency contexts.
  
• Other Routes (Not Common): Currently, there is no approved nasal spray or subcutaneous form of Nalmefene in widespread use. 

Should Nalmefene Be Taken With or Without Food?

Yes, Nalmefene can be taken with or without food. According to the European Medicines Agency’s product information for Selincro (Nalmefene), food intake does not significantly impact the drug’s absorption or effectiveness. Clinical pharmacokinetic studies have shown that while a high-fat meal slightly delays the time it takes for Nalmefene to reach peak blood levels, it does not reduce its overall efficacy in treating alcohol dependence. 

What Should You Do If You Miss a Dose of Nalmefene?

Take the missed dose of Nalmefene as soon as you remember, especially if alcohol consumption is still anticipated. However, if it’s close to the time of your next planned dose, skip the missed dose and continue with your usual schedule. Do not double up on doses to make up for a missed one. 

What Are the Side Effects of Nalmefene?

The side effects of Nalmefene are nausea, dizziness, insomnia, and headache. These side effects are primarily related to its role as an opioid receptor modulator. According to the Royal Free London NHS Foundation Trust, these symptoms are mild to moderate and occur during the initial weeks of treatment. 

The side effects of Nalmefene are as follows:

Common Side Effects of Nalmefene

Most users experience manageable side effects, particularly during the early phase of treatment. These symptoms improve with continued use.

Common side effects of Nalmefene include:

• Nausea: Nausea is the most frequently reported side effect, affecting 34.2% of users, particularly during the initial phase of treatment, according to the Royal Free London NHS Foundation Trust.
• Dizziness: Dizziness occurs in about 18.0% of patients and is commonly experienced in the early stages of use, which lessens over time, as noted by the Royal Free London NHS Foundation Trust. 
• Insomnia: Insomnia affects approximately 12.4% of individuals taking Nalmefene, potentially disrupting sleep patterns, especially during the first few weeks of therapy, as reported by the Royal Free London NHS Foundation Trust. 
• Headache: Headache, usually mild, is experienced by 11.8% of users and decreases with continued use, according to the Royal Free London NHS Foundation Trust. 
• Fatigue: Fatigue is another common complaint, particularly during dose initiation, with patients reporting persistent tiredness. 
• Dry Mouth: Dry mouth occurs temporarily and is usually manageable with increased fluid intake. 
• Increased Sweating: Increased sweating is occasionally reported, especially during physical activity or stressful situations. 
• Decreased Appetite: Decreased appetite is also noted in some cases, which leads to slight weight loss over time. 

Serious Side Effects of Nalmefene

Serious adverse effects are less common but require immediate discontinuation and medical attention.

Serious side effects of Nalmefene include:

• Psychiatric Disturbances: Psychiatric disturbances such as anxiety, confusion, and hallucinations have been reported, particularly in individuals with pre-existing mental health conditions. A case study by Salles J, Ponté C, Schmitt L. et al. 2019, titled “Psychotic Decompensation During Nalmefene Treatment in a Patient With Schizoaffective Disorder: A Case Report,” documented psychotic decompensation in a patient with schizoaffective disorder during Nalmefene treatment, underscoring the need for psychiatric evaluation.
• Suicidal Ideation: Suicidal ideation has been observed in some patients taking Nalmefene, with reports linking the drug to an increase in suicidal thoughts. 
• Liver Toxicity: Liver toxicity, while rare, has been associated with elevated hepatic enzymes, particularly in those with underlying liver disease. According to the National Institute of Diabetes and Digestive and Kidney Diseases 2012, titled “Naltrexone,” liver function should be regularly monitored during Nalmefene treatment.
• Precipitated Opioid Withdrawal: Precipitated opioid withdrawal occurs if Nalmefene is given to individuals unknowingly dependent on opioids. This results in severe symptoms such as agitation, vomiting, and sweating due to its potent opioid antagonist action.
• Gastrointestinal Distress: Gastrointestinal distress, including severe nausea and vomiting, has led to discontinuation of Nalmefene treatment in some patients. 
• Excessive Sweating and Shaking: Excessive sweating and shaking are commonly linked to acute withdrawal episodes triggered by Nalmefene. These symptoms are more likely in opioid-dependent individuals and require medical supervision.
• Cardiovascular Issues: Cardiovascular issues, though uncommon, include fluctuations in blood pressure or heart rate. 
• Debilitating Fatigue: Debilitating fatigue has been reported in certain cases, causing significant weakness that interferes with daily activities. 

What Are the Alternatives to Nalmefene for Alcohol Addiction?

The alternatives to Nalmefene for alcohol addiction are Naltrexone, Acamprosate, and Disulfiram, all of which are FDA-approved. These medications differ in their mechanisms of action, with some helping to reduce cravings, others maintaining abstinence, or creating an aversive reaction to drinking. 

The alternatives to Nalmefene for alcohol addiction are as follows:

Naltrexone

Naltrexone is an opioid receptor antagonist taken daily to reduce the pleasurable effects of alcohol. It works by blocking endorphin release triggered by alcohol consumption, thereby reducing the urge to drink. Clinical research by Anton RF et al. 2008, titled “Naltrexone for the management of alcohol dependence,” demonstrates its ability to decrease heavy drinking days by up to 25%, making it one of the most commonly prescribed treatments for alcohol addiction in the United States.

Acamprosate

Acamprosate (Campral) is a neuromodulator that restores balance to glutamate and GABA activity in the brain, which is disrupted by chronic alcohol use. Acamprosate is designed to help individuals who have already stopped drinking stay sober. A study by Mason BJ and Heyser CJ 2010, titled “Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence,” supports Acamprosate use in preventing relapse and maintaining long-term abstinence when taken 3 times daily.

Disulfiram

Disulfiram (Antabuse) is an aversive therapy that deters alcohol consumption by causing a severe physical reaction when alcohol is ingested, such as nausea, vomiting, and palpitations. It does not affect cravings but is highly effective for individuals committed to sobriety who need external reinforcement. 

How Does Nalmefene Differ from Other Alcohol Addiction Medications?

Nalmefene differs from other alcohol addiction medications in its dosing strategy and mechanism. Unlike Naltrexone, which is taken daily, Nalmefene is used on an as-needed basis before anticipated drinking. This allows for more flexibility and supports harm reduction rather than enforcing abstinence. It also acts as a partial agonist at kappa-opioid receptors, unlike other treatments that are purely antagonistic, which help reduce stress-related drinking behaviors.

Who Should Not Take Nalmefene?

Individuals with certain health conditions, like kidney impairment and a history of psychosis, should not take Nalmefene due to safety concerns. Individuals with severe liver or kidney impairment should avoid Nalmefene, as the drug is metabolized and excreted through these organs, and compromised function increases toxicity. 

People experiencing acute alcohol withdrawal are also advised against its use, as it worsens withdrawal symptoms. Patients who are dependent on opioids should not take Nalmefene since it causes precipitated withdrawal by suddenly blocking opioid receptors. 

Can You Take Nalmefene During Pregnancy?

No, you cannot take Nalmefene during pregnancy or breastfeeding. Animal studies by Medscape have shown adverse effects on fetal development, and there is limited human clinical data to confirm safety. 

Do You Need a Prescription for Nalmefene in Florida?

Yes, you need a prescription for Nalmefene in Florida, as it is a regulated medication used for alcohol use disorder. Nalmefene must be prescribed by a licensed healthcare professional after assessing the patient’s medical history and treatment needs.

Can You Stop Taking Nalmefene Suddenly?

Yes, you can stop taking Nalmefene suddenly without experiencing withdrawal symptoms. Unlike opioids or certain psychiatric medications, Nalmefene does not cause physiological dependence and can be discontinued without tapering and experiencing any withdrawal symptoms.

How Long Does Nalmefene Stay in Your System?

Nalmefene stays in your system for approximately 24 hours after a single dose. Its half-life is around 10 to 11 hours, meaning it takes that long for the drug’s concentration in the blood to reduce by half. Due to this duration, it offers prolonged opioid receptor blockade, which is especially useful in alcohol reduction strategies.